Disease characteristics in Belgian myelofibrosis patients and management guidelines anno 2013

Diagnostic and management guidelines for myelofibrosis patients are presented in this paper. As a consequence of the rapid evolution and progress in this domain over the last years, the need was felt by the BHS MPN subcommittee to update these guidelines for our country. The different prognostic scores in myelofibrosis, the diagnostic tools and treatment options with the focus on new possibilities are discussed.

Verfasser: Devos, Timothy
Straetmans, Nicole
Schuermans, Christine
Benghiat, Fleur Samantha
Robin, Valérie
Lewalle, Philippe
Mineur, Philippe
Verhoef, Gregor
Knoops, Laurent
Dokumenttyp: Artikel
Erscheinungsdatum: 2013
Verlag/Hrsg.: Ariez International B.V.
Schlagwörter: Guidelines / JAK2 inhibitors / Myelofibrosis / Prognostic scores
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29295134
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/213078